One Rock Capital Partners Completes Strategic Investment to Create Eat Happy Hana Group July 27, 2026 One Rock Capital Partners, LLC (“One Rock”) today announced that EAT HAPPY GROUP (“EAT HAPPY”) and the European operations of Hana Group SAS (“Hana”) have successfully completed their previously announced combination, supported by a strategic investment from One Rock. Following receipt of all required regulatory approvals, the transaction has now closed. The combined business will [...]
Kuwait Oil Company Signs US$ 16.0 Billion Infrastructure Partnership Involving Its Crude Oil Pipeline Network With a Consortium Comprising Blackstone, Brookfield and KKR July 25, 2026 Kuwait Oil Company (“KOC”) is establishing a new joint venture (“JV”) with three leading global investors in a lease and leaseback structure for a 20.5 year period that includes a volume-based tariff Following a competitive selection process, Blackstone, Brookfield and KKR will collectively hold a 49% stake in the JV, with each investor holding an equal one-third share of that interest on equal terms; KOC will retain a 51% stake and full ownership and operational control of the network Kuwait's largest energy infrastructure partnership to date, and the largest foreign direct investment ever in Kuwait Marks the first time leading global institutional investors have deployed long-term capital into Kuwait’s midstream infrastructure Underscores – amidst ongoing regional geopolitical challenges – international trust in KPC’s ability to deliver on its 2040 Strategy to reach 4 million barrels of crude oil production capacity per day by 2035 Supports Kuwait's economic diversification goals in a partnership with leading international investors, expected to generate US$ 7.85 billion of proceeds to support broader capital expenditure plans Preserves the State of Kuwait’s full flexibility over its production and refining volumes
Algoma Central Corporation to Issue Second Quarter Financial Results on August 7, 2026 July 24, 2026 Algoma Central Corporation (TSX: ALC) today announced it will report its financial results for the three and six months ended June 30, 2026 before market open on August 7, 2026. The Company’s second quarter earnings release and full financial results will be available on the Company’s website and on SEDAR. Algoma Central Corporation is a [...]
Mobix Labs Signs Definitive Agreement to Acquire Vision Aerial, Accelerating Global Drone Platform for National Security and Aerial Intelligence July 24, 2026 Transaction accelerates Mobix Labs’ global aerial intelligence strategy and National Security Matters Initiative
Result of AngloGold Ashanti plc’s General Meeting July 24, 2026 AngloGold Ashanti plc (the “Company”) (NYSE: AU; JSE: ANG) today announces the result of the general meeting of its shareholders held at 9:00am (Mountain Daylight Time) on Thursday, 23 July 2026 (the “General Meeting”). The full text of the resolution proposed at the General Meeting is set out in the notice of General Meeting (the [...]
U.K. Enterprises Adopt AI-Augmented Operations July 24, 2026 Organizations prioritize governed AI, employee experience and measurable productivity outcomes as workplace transformation matures, ISG Provider Lens® report says
Comsysto Reply Supports Audi in Evolving Its B2B Used Car Platform With an AI-Based Multi-Agent System July 24, 2026 Comsysto Reply, the Reply Group company specialised in agile software development and cloud-native solutions, has partnered with Audi on the ongoing development of its “Used Car Platform”, the company’s central digital marketplace for B2B used car trading. A tailored multi-agent solution accelerates software development, reduces repetitive activities, and enables faster delivery of new features. This [...]
NADclinic and GCLS Announce Strategic Collaboration in Longevity and Performance Medicine Education July 24, 2026 International collaboration to expand clinician education, professional standards and responsible adoption across longevity and performance medicine
Almirall H1 2026 Results July 24, 2026 Almirall delivers solid H1 2026 results growing Net Sales by 7.5% and EBITDA by 23.7%, driven by its strong European Dermatology business – reiterating guidance aligned with long-term growth trajectory Net Sales increased by 7.5% YoY to €602.7 MM, while EBITDA grew by 23.7% to €150.7 MM, reflecting strong commercial and operational execution. The European Dermatology business continues to drive growth, increasing 18.1% YoY to €341.9 MM, supported by strong performance of its key growth drivers and favourable underlying market growth. Continued solid performance of the biologics portfolio, with Ilumetri® delivering 10.5% increase to €125.2 MM and Ebglyss® growing 88.2% to €84.5 MM in Net Sales, supported by sustained growth in recent launch markets. The broader dermatology portfolio delivers positive performance, including Wynzora® (19.3%, total of €20.4 MM) and Klisyri® (13.9%, total of €15.6 MM). Almirall advances its innovation strategy through progress across its R&D pipeline, including four ongoing PoC/Phase II studies and two additional PoC studies planned to be initiated by end of 2026, targeting five dermatological diseases. The first readouts are expected towards the end of 2026. Almirall signs a strategic research collaboration and licensing agreement with Certest Biotec to discover and develop novel treatments for rare dermatologic diseases and recurrent cutaneous conditions. Reiterated guidance for the full year 2026: 9-12% growth and € 270MM to € 290MM EBITDA.
Francisco Partners Closes $21 Billion Across Flagship and Agility Funds July 23, 2026 Largest fundraise in the firm’s history brings total capital raised to more than $75 billion